To evaluate the longterm safety of adalimumab administered with or without methotrexate ( MTX ) and compare the efficacy of combination therapy initialization to adalimumab or MTX monotherapy initialization during the open-label extension ( OLE ) of the PREMIER trial ( ClinicalTrials.gov Identifier : NCT00195663 ) .